[go: up one dir, main page]

FR3061151B1 - METHOD AND SYSTEM FOR CONDITIONING LIPID COMPOUND IN DOSES, LIPID COMPOUND CAPSULES THUS OBTAINED AND APPLICATIONS THEREOF - Google Patents

METHOD AND SYSTEM FOR CONDITIONING LIPID COMPOUND IN DOSES, LIPID COMPOUND CAPSULES THUS OBTAINED AND APPLICATIONS THEREOF Download PDF

Info

Publication number
FR3061151B1
FR3061151B1 FR1663399A FR1663399A FR3061151B1 FR 3061151 B1 FR3061151 B1 FR 3061151B1 FR 1663399 A FR1663399 A FR 1663399A FR 1663399 A FR1663399 A FR 1663399A FR 3061151 B1 FR3061151 B1 FR 3061151B1
Authority
FR
France
Prior art keywords
lipid compound
conditioning
doses
applications
capsules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1663399A
Other languages
French (fr)
Other versions
FR3061151A1 (en
Inventor
Bernard Jacques Kurdyk
Jean-Pierre Lablanchy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Belles Feuilles
Cabinet Du Docteur Bernard Kurdyk
Original Assignee
Belles Feuilles
Cabinet Du Docteur Bernard Kurdyk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Belles Feuilles, Cabinet Du Docteur Bernard Kurdyk filed Critical Belles Feuilles
Priority to FR1663399A priority Critical patent/FR3061151B1/en
Priority to PCT/EP2017/084261 priority patent/WO2018122129A1/en
Publication of FR3061151A1 publication Critical patent/FR3061151A1/en
Application granted granted Critical
Publication of FR3061151B1 publication Critical patent/FR3061151B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00—Preservation of foods or foodstuffs, in general
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B20/00—Preservation of edible oils or fats
    • A23B20/30—Preservation of other edible oils or fats, e.g. shortenings or cooking oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
    • A61J3/072—Sealing capsules, e.g. rendering them tamper-proof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
    • A61J3/074—Filling capsules; Related operations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Manufacturing Of Micro-Capsules (AREA)

Abstract

Procédé pour conditionner un composé lipidique sous la forme d'une dose adaptée à un usage fonctionnel, comprenant les étapes suivantes : - remplissage (I) d'une première partie d'une capsule préfabriquée, préalablement ouverte en deux parties, avec un volume prédéterminé d'un composé lipidique; - insertion (II) d'un absorbant lipophile dans le composé lipidique au sein de la première partie, de façon à réaliser, à l'issue de l'absorption du composé lipidique, un cœur sous la forme d'un mélange pâteux procurant une vitesse de dissolution prédéterminée, et - fermeture (III) de la capsule en plaçant la seconde partie sur la première partie contenant ce cœur.Process for conditioning a lipid compound in the form of a dose adapted for functional use, comprising the following steps: filling (I) of a first part of a prefabricated capsule, previously opened in two parts, with a predetermined volume a lipid compound; - insertion (II) of a lipophilic absorbent in the lipid compound in the first part, so as to achieve, after absorption of the lipid compound, a heart in the form of a pasty mixture providing a predetermined dissolution rate, and - closing (III) of the capsule by placing the second portion on the first portion containing this heart.

FR1663399A 2016-12-26 2016-12-26 METHOD AND SYSTEM FOR CONDITIONING LIPID COMPOUND IN DOSES, LIPID COMPOUND CAPSULES THUS OBTAINED AND APPLICATIONS THEREOF Expired - Fee Related FR3061151B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1663399A FR3061151B1 (en) 2016-12-26 2016-12-26 METHOD AND SYSTEM FOR CONDITIONING LIPID COMPOUND IN DOSES, LIPID COMPOUND CAPSULES THUS OBTAINED AND APPLICATIONS THEREOF
PCT/EP2017/084261 WO2018122129A1 (en) 2016-12-26 2017-12-21 Process and system for packaging a lipid-based compound in doses, capsules of lipid-based compound thus obtained and applications of these capsules

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1663399A FR3061151B1 (en) 2016-12-26 2016-12-26 METHOD AND SYSTEM FOR CONDITIONING LIPID COMPOUND IN DOSES, LIPID COMPOUND CAPSULES THUS OBTAINED AND APPLICATIONS THEREOF
FR1663399 2016-12-26

Publications (2)

Publication Number Publication Date
FR3061151A1 FR3061151A1 (en) 2018-06-29
FR3061151B1 true FR3061151B1 (en) 2019-05-24

Family

ID=59070718

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1663399A Expired - Fee Related FR3061151B1 (en) 2016-12-26 2016-12-26 METHOD AND SYSTEM FOR CONDITIONING LIPID COMPOUND IN DOSES, LIPID COMPOUND CAPSULES THUS OBTAINED AND APPLICATIONS THEREOF

Country Status (2)

Country Link
FR (1) FR3061151B1 (en)
WO (1) WO2018122129A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020161398A1 (en) 2019-02-07 2020-08-13 Belles Feuilles Composition and gel capsules containing same, in particular for reducing or removing a biofilm

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9509764D0 (en) * 1995-05-15 1995-07-05 Tillotts Pharma Ag Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids

Also Published As

Publication number Publication date
FR3061151A1 (en) 2018-06-29
WO2018122129A1 (en) 2018-07-05

Similar Documents

Publication Publication Date Title
WO2016172396A3 (en) Multi-chamber sequential delivery syringe
HRP20241087T1 (en) CONJUGATED OPPOSITE COMPOUNDS FOR USE IN THERAPY
NZ710471A (en) Sustained-release lipid pre-concentrate of anionic pharmacologically active substances and pharmaceutical composition comprising the same
WO2016100949A3 (en) Method and compositions for dissolving or solubilizing therapeutic agents
CR20160037A (en) STABILIZED PHARMACEUTICAL DOSAGE FORMS THAT INCLUDE BACK
FR3061151B1 (en) METHOD AND SYSTEM FOR CONDITIONING LIPID COMPOUND IN DOSES, LIPID COMPOUND CAPSULES THUS OBTAINED AND APPLICATIONS THEREOF
EP2486914A3 (en) Stable, non-corrosive formulations for pressurized metered dose inhalers
RU2020120876A (en) A PHARMACEUTICAL COMPOSITION CONTAINING ANTAGONIST OF MINERALOCORTICOID RECEPTORS AND ITS APPLICATION
BR112017025527A2 (en) liquid pharmaceutical preparation, and method for making a cellocoxib suspension.
WO2008077772A3 (en) Combination of a retinoid and a platinum anticancer agent
Srinivasan Glibenclamide/glibenclamide interaction/overdose
RU2005109451A (en) METHOD FOR MODELING CHRONIC TOXIC NEPHROPATHY
Kaya et al. Severe hyponatremia, epistaxis, and fluoxetine
Kataoka Eruptions in an elderly patient: case report
Suzuki Hypersensitivity reaction and acute thrombocytopenia in an elderly patient: case report
Sanai Propylthiouracil/thiamazole
Shawa Unilateral renal artery stenosis with renal atrophy: case report
Gisslinger Development of resistance: 2 case reports
O’Brien Liver dysfunction and liver failure: case report
Ambadas et al. Liquisolid Technique a Novel Approach to Enhance Solubility and Dissolution Rate: A Review
Yamashita Diarrhoea in an elderly patient: case report
Horn Hypokalaemia associated with systemic toxicity: case report
Nadiradze Cisplatin/doxorubicin
Ersoy Isotretinoin/methylphenidate
Carpenter Bruising: case report

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20180629

PLFP Fee payment

Year of fee payment: 4

ST Notification of lapse

Effective date: 20210806